Long-term etanercept in pediatric patients with plaque psoriasis
- 30 November 2010
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 63 (5), 762-768
- https://doi.org/10.1016/j.jaad.2010.04.004
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Long‐term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritisArthritis & Rheumatism, 2009
- Etanercept Treatment for Children and Adolescents with Plaque PsoriasisNew England Journal of Medicine, 2008
- Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With PsoriasisArchives of Dermatology, 2007
- Long‐term safety and efficacy of etanercept in children with polyarticular‐course juvenile rheumatoid arthritisArthritis & Rheumatism, 2006
- Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trialThe Lancet, 2005
- A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reductionBritish Journal of Dermatology, 2005
- A Randomized Trial of Etanercept as Monotherapy for PsoriasisArchives of Dermatology, 2003
- Etanercept as Monotherapy in Patients with PsoriasisNew England Journal of Medicine, 2003
- Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trialArthritis & Rheumatism, 2003